-
Thematic Analysis
The Future of Pharma​ - Looking Ahead to 2026
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Sector Analysis
Venous Thromboembolism Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
According to GlobalData estimates, 2024 base year sales within the VTE market are approximately $3.93 billion across 7MM and will grow at a compound annual growth rate (CAGR) of 2.6% to reach $5.10 billion by the end of the forecast period. VTE is a disease that includes a myriad of life-threatening disorders ranging from PE to DVT. The condition is relatively prevalent and is associated with long-term mortality and morbidity
-
Track & Monitor
Venture Capital Investment Trends in Pharma - Q1 2026
This report analyzes the venture capital (VC) investment activity in Q1 2026 in the Pharma sector.
-
Track & Monitor
Merger & Acquisition Trends in Pharma - Q1 2026
This report analyzes the merger and acquisition (M&A) activity in Q1 2026 in the Pharma sector.
-
Sector Analysis
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Pre-Conference Coverage
ESCMID Global is the annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (formerly ECCMID). The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Annual Meeting 2026 will take place in Munich, Germany, between April 17 Â and 21. In advance of the confernece, GlobalData highlighted highly anticipated and noteworthy abstracts in this Pre-Conference Coverage report.
-
Sector Analysis
Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Thyroid Cancer Therapeutics._x000D_ _x000D_ • In 2024 and 2029, China is anticipated to have the highest number of diagnosed prevalent cases of thyroid cancer, representing a large portion of global cases._x000D_ • Currently, approved targeted therapies have already become a part of the standard care for advanced thyroid cancer (with drugs selected based on the tumor’s genetic profile), and immunotherapies are emerging as experimental options that...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, March 2026
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Sector Analysis
Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
The report provides an in-depth assessment of the HIV market including disease overview, epidemiology, disease management, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, current and future players, and market outlook. Over four decades ago, researchers identified the human immunodeficiency virus (HIV) as the causative agent of a then-mysterious new illness, acquired immunodeficiency syndrome (AIDS). A member of the Lentivirus genus, HIV belongs to the family of retroviruses, RNA viruses with the ability to reverse transcribe their...
-
Sector Analysis
Venous Thromboembolism (VTE): Epidemiology Forecast to 2034
Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially fatal condition which impedes blood flow by causing blood clots (thrombosis) (Wendelboe et al., 2021). In a VTE, a DVT is a clot that occurs only in the veins; DVT is commonly found in the legs and pelvis (proximally) but can also occur in the upper body (distally) (Henke et al., 2020). If the DVT travels from its original location through the circulatory system...
-
Product Insights
Systemic Lupus Erythematosus - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Systemic Lupus Erythematosus - Global Clinical Trials Review, 2026" provides an overview of Systemic Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.